⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3262657 | 1.00 | CYP2D6 (0.60) | — | |
| SCHEMBL19307 | 1.00 | — | — | |
| SCHEMBL22792 | 1.00 | — | — | |
| SCHEMBL200243 | 1.00 | — | — | |
| SCHEMBL85624 | 1.00 | — | — | |
| SCHEMBL1995473 | 1.00 | — | — | |
| SCHEMBL6858335 | 1.00 | CYP2D6 (0.60) | — | |
| SCHEMBL21185 | 1.00 | — | — | |
| SCHEMBL21184 | 1.00 | — | — | |
| SCHEMBL2024894 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140155371-A1 | MULTICOMPONENT CRYSTALLINE SYSTEM OF EZETIMIBE AND PROLINE | BASF SE (DE) | 2014-06-05 | — | — | US | claimed |
| EP-2575852-A1 | ANTIMICROBIAL PEPTIDES AND PEPTIDE DERIVATIVES DERIVED FROM ONCOPELTUS FASCIATUS | AMP Therapeutics GmbH (DE) | 2013-04-10 | — | — | EP | claimed |
| WO-2013014604-A1 | MULTICOMPONENT CRYSTALLINE SYSTEM OF EZETIMIBE AND PROLINE | BASF SE (DE) | 2013-01-31 | — | — | WO | claimed |
| WO-2011147960-A1 | ANTIMICROBIAL PEPTIDES AND PEPTIDE DERIVATIVES DERIVED FROM ONCOPELTUS FASCIATUS | AMP-THERAPEUTICS GMBH & CO. KG (DE) | 2011-12-01 | — | — | WO | claimed |
| EP-4608509-A1 | NEW INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE | Institut National de la Santé et de la Recherche Médicale (FR) | 2025-09-03 | — | — | EP | disclosed |
| WO-2024089272-A1 | NEW INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) | 2024-05-02 | — | — | WO | disclosed |
| US-20230212549-A1 | COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE THEREOF | 3B PHARMACEUTICALS GMBH (DE) | 2023-07-06 | — | — | US | disclosed |
| EP-3643703-A1 | EP300/CREBBP INHIBITOR | Daiichi Sankyo Co., Ltd. (JP) | 2020-04-29 | — | — | EP | disclosed |
| US-10328051-B2 | Proline or proline derivatives for the treatment of dementia | SALAMA ZOSER B (DE) | 2019-06-25 | — | — | US | disclosed |
| WO-2019104011-A1 | CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE | BIOMARIN PHARMACEUTICAL INC. (US) | 2019-05-31 | — | — | WO | disclosed |
| EP-3344616-A1 | SUBSTITUTED AMINO TRIAZOLES USEFUL AS HUMAN CHITINASE INHIBITORS | ONCOARENDI THERAPEUTICS S.A. (PL) | 2018-07-11 | — | — | EP | disclosed |
| US-20170239215-A1 | PROLINE OR PROLINE DERIVATIVES FOR THE TREATMENT OF DEMENTIA | SALAMA ZOSER B (DE) | 2017-08-24 | — | — | US | disclosed |
| WO-2000014201-A1 | POLYPEPTIDES CONTAINING MODIFIED, NON-NATURAL AMINO ACIDS AND METHODS OF PRODUCTION | UNITED STATES SURGICAL CORPORATION (US) | 2000-03-16 | — | — | WO | disclosed |
| WO-2000009558-A1 | HEPATITIS C INHIBITOR PEPTIDES | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2000-02-24 | — | — | WO | disclosed |
| WO-2000008197-A1 | METHOD FOR THE PRODUCTION OF AN ANTIBIOTIC AGENT | MERCK & CO., INC. (US) | 2000-02-17 | — | — | WO | disclosed |
| WO-1999050415-A2 | PROTEASE-ACTIVATED RECEPTOR PAR4 (ZCHEMR2) | ZYMOGENETICS, INC. (US) | 1999-10-07 | — | — | WO | disclosed |
| US-5552405-A | TREATMENT OF AIDS, ACTIVITY AGAINST RETROVIRUSES | BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH, INC. (CA) | 1996-09-03 | — | — | US | disclosed |
| EP-0560269-B1 | Substituted pyrrolidine derivatives as HIV protease inhibitors | BIO MEGA BOEHRINGER INGELHEIM (CA) | 1995-05-31 | — | — | EP | disclosed |
| EP-0560269-A1 | Substituted pyrrolidine derivatives as HIV protease inhibitors | BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) | 1993-09-15 | — | — | EP | disclosed |
| EP-0053902-B1 | PHOSPHINYLALKANOYL SUBSTITUTED PROLINES | E.R. Squibb & Sons, Inc. (US) | 1985-04-03 | — | — | EP | disclosed |